3D Biotek, LLC. and Irina Briller
MBA from Rutgers University,
Using its Precision 3D Microfabrication technology, 3D Biotek is engaged in the development of novel 3-dimensional scaffolds for drug discovery, stem cell research and tissue engineering applications. Through its vigorous product development and R&D effort in the past, the company had successfully launched two products, namely 3D-Insert-PCL and 3D-Insert-PS, to the market. Both of them have been shown to have huge potential in drug screening and stem cell differentiation studies. These products are truly novel products in the market due to their unique features. As such, the company is focusing on penetrating the market with these novel products this year.
Switch2Health, Inc., and Goutham Bhardi,
MBA, Columbia University, NY
Switch2Health® (S2H) is the leading enabler of improved Health & Wellness through motivating and rewarding people for physical activity. The real challenge is creating incentive and motivation for individuals to be physically active.
S2H has launched S2H.COM, a destination website that enables individuals to be rewarded for their physical activity. By integrating products based on patent pending S2H technology, the website allows users to earn rewards for their physical activity, challenge other users in a competitive environment, and interact socially within the S2H.COM community.